Pharmacokinetics of Risankizumab in Asian Healthy Subjects and Patients With Moderate to Severe Plaque Psoriasis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis

Risankizumab, a humanized monoclonal antibody that targets interleukin‐23 p19 subunit, was developed for the treatment of psoriasis. This work characterizes risankizumab pharmacokinetics in Japanese and Chinese healthy subjects compared with white healthy subjects and in Japanese patients with moder...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Clin Pharmacol
Main Authors: Khatri, Amit, Eckert, Doerthe, Oberoi, Rajneet, Suleiman, Ahmed, Pang, Yinuo, Cheng, Ling, Othman, Ahmed A.
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2019
主題:
Pharmacokinetics
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6852105/
https://ncbi.nlm.nih.gov/pubmed/31257614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.1473
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍